114 related articles for article (PubMed ID: 12160583)
21. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer.
Durand M; Barret E; Galiano M; Rozet F; Sanchez-Salas R; Ahallal Y; Macek P; Gaya JM; Cerruti J; Devilliers H; Loeffler J; Amiel J; Vallancien G; Cathelineau X
BJU Int; 2014 Jan; 113(1):56-64. PubMed ID: 24053685
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical stage C adenocarcinoma of the prostate.
Miller RJ; Cohen JK; Merlotti LA
Urology; 1994 Aug; 44(2):170-4. PubMed ID: 8048190
[TBL] [Abstract][Full Text] [Related]
23. [Role of transrectal ultrasonography in the follow-up of patients treated with prostatic cryosurgery].
Galosi AB; Muzzonigro G; Polito M; Minardi D; Dellabella M; Lugnani F; Polito M
Arch Ital Urol Androl; 2000 Dec; 72(4):276-81. PubMed ID: 11221054
[TBL] [Abstract][Full Text] [Related]
24. [Cryosurgical ablation for 23 cases of prostate cancer guided by rectal ultrasound].
Wu Q; Wang XS; Qian JX; Zhang JX; Xu Q; Cao CW; Gu XQ; Luo YZ; Wang JJ
Zhonghua Nan Ke Xue; 2005 Sep; 11(9):670-3. PubMed ID: 16209207
[TBL] [Abstract][Full Text] [Related]
25. Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate.
Cox RL; Crawford ED
Urology; 1995 Jun; 45(6):932-5. PubMed ID: 7771025
[TBL] [Abstract][Full Text] [Related]
26. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.
Lambert EH; Bolte K; Masson P; Katz AE
Urology; 2007 Jun; 69(6):1117-20. PubMed ID: 17572198
[TBL] [Abstract][Full Text] [Related]
27. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate.
Onik GM; Cohen JK; Reyes GD; Rubinsky B; Chang Z; Baust J
Cancer; 1993 Aug; 72(4):1291-9. PubMed ID: 7687922
[TBL] [Abstract][Full Text] [Related]
28. Prostate-specific antigen after cryosurgical ablation of the prostate. Defining the appropriate response.
Connolly JA; Shinohara K; Presti JC; Carroll PR
Urol Clin North Am; 1997 May; 24(2):415-20. PubMed ID: 9126239
[TBL] [Abstract][Full Text] [Related]
29. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.
Inoue Y; Goto K; Hayashi T; Hayashi M
Int J Urol; 2011 May; 18(5):358-62. PubMed ID: 21449970
[TBL] [Abstract][Full Text] [Related]
30. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
31. [Ultrasound-guided cryosurgery of the prostate: short- and long-term experience].
Minardi D; Polito M; Galosi AB; Yehia M; Dellabella M; Lugnani F; Muzzonigro G
Arch Ital Urol Androl; 2000 Dec; 72(4):270-5. PubMed ID: 11221053
[TBL] [Abstract][Full Text] [Related]
32. Prostate cancer: US-guided percutaneous cryoablation. Work in progress.
Bahn DK; Lee F; Solomon MH; Gontina H; Klionsky DL; Lee FT
Radiology; 1995 Feb; 194(2):551-6. PubMed ID: 7529937
[TBL] [Abstract][Full Text] [Related]
33. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
[TBL] [Abstract][Full Text] [Related]
34. Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: quality of life in high-risk prostate cancer patients.
Kang SH; Kim JW; Bae JH; Park HS; Moon DG; Yoon DK; Cheon J; Kim JJ
Asian J Androl; 2006 Sep; 8(5):629-36. PubMed ID: 16847531
[TBL] [Abstract][Full Text] [Related]
35. Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer.
Ficarra V; Antoniolli SZ; Novara G; Parisi A; Fracalanza S; Martignoni G; Artibani W
BJU Int; 2006 Dec; 98(6):1193-8. PubMed ID: 17125477
[TBL] [Abstract][Full Text] [Related]
36. The feasibility and safety of repeat cryosurgical ablation of localized prostate cancer.
Mustafa M; Delacroix S; Ward JF; Pisters L
World J Surg Oncol; 2015 Dec; 13():340. PubMed ID: 26691335
[TBL] [Abstract][Full Text] [Related]
37. Dose response in prostate cancer with 8-12 years' follow-up.
Hanks GE; Hanlon AL; Epstein B; Horwitz EM
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):427-35. PubMed ID: 12243818
[TBL] [Abstract][Full Text] [Related]
38. Salvage prostate cryoablation: initial results from the cryo on-line data registry.
Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS
J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664
[TBL] [Abstract][Full Text] [Related]
39. Cryosurgical ablation of the prostate.
Keetch DW; Moore S; Shea L
AORN J; 1995 May; 61(5):807-13; quiz 816-7, 819-20. PubMed ID: 7611737
[TBL] [Abstract][Full Text] [Related]
40. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A; Walter B; Rogenhofer S; Wieland WF
Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
